Pharmacotherapy of Oral Diabetes and Non-Insulin Injectable Medications Flashcards

1
Q

What are the hallmark symptoms of hyperglycemia?

A

Polydipsia, Polyuria, and Polyphagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the reasons for an alternate goal?

A

High risk for hypoglycemia, high risk for complication of hypoglycemia occurs, barriers to drug therapy required for optimal control, lower risk for chronic complications, and elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the A1c goal of healthy patient with few coexisting chronic illnesses and intact cognitive function?

A

<7-7.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the A1c goal for a complex patient with multiple coexisting chronic illnesses with mild cognitive impairment?

A

<8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the A1c goal of a very complex end stage chronic illness with mod/severe cognitive impairment?

A

Avoid reliance on A1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the primary action of Metformin?

A

Decreases hepatic glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the use of Metformin?

A

Should always be considered in type 2 DM unless there is a CI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the dose adjustment of Metformin for eGFR >45?

A

No adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the dose adjustment of Metformin for eGFR 30-45?

A

Can initiate at 500 mg QD and titrate to 500 mg BID for new therapy
Continuation of therapy = 50% REDUCTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the max dose of Metformin in eGFR 30-45?

A

1 g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the dose adjustment of Metformin for eGFR <30?

A

CI due to increased risk of lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the A/Es of Metformin?

A

Diarrhea and Decreased B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the warnings/DIs of Metformin?

A

Lactic Acidosis or Age >80 due to decreased renal clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do you monitor for Metformin?

A

Renal Function and B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the place in therapy for Metformin?

A

First Line
A1c Lowering 1.5-2%
Highest lowering effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the pearls of Metformin?

A

Improve HDL and LDL, Max Dose = 2000mg, Weight Neutral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the primary action of Sulfonylureas?

A

Increases insulin secretion = glucose INDEPENDENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the brand name of Glimepiride?

A

Amaryl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When do you avoid Amaryl?

A

Avoid eGFR <15 other than that no renal dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the brand name of Glipizide?

A

Glucotrol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Do you renally dose adjust in Glucotrol?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the brand name of Glyburide?

A

Glynase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When is Glynase not recommended?

A

eGFR <60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the A/Es of Sulfonylureas?

A

Hypoglycemia and Weight Gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What do you monitor in Sulfonylureas?

A

Hypoglycemia and Renal Function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the place of therapy for Sulfonylureas?

A

2nd or 3rd line
A1c lowering 1-2% (better as mono therapy and not adjunct)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What 2 Sulfonylurea’s are on the BEER’s List?

A

Glyburide and Glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the primary action of Meglitinides?

A

Increases insulin secretion, glucose DEPENDENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the brand name of Repaglinide?

A

Prandin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the brand name of Nateglinide?

A

Starlix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the A/E of Meglitinides?

A

Hypoglycemia and Weight Gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the warning associated with Meglitinides?

A

Not recommended to use together with SU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the place in therapy of Meglitinides?

A

2nd or 3rd line
A1c lowering 0.8-1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the pearls of Meglitinides?

A

Skip is the patient skips a meal, however useful for patients with inconsistent eating patterns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is the primary action of Thiazolidinediones?

A

Increased insulin sensitivity, takes 6-12 wks for MAX effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the brand name of Pioglitazone?

A

Actos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is the brand name of Rosiglitazone?

A

Avandia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

When do you DC TZD therapy?

A

When LFTs are elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the A/Es of TZDs?

A

Peripheral edema/fluid retention, elevated LFTs, and weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is a CI of TZDs?

A

NYHA III or IV Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is a warning of TZDs?

A

Can exacerbate HF at any stage with fluid retention (black box) and hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What do you monitor with TZDs?

A

LFT, Alkaline phosphatase, and total bilirubin at baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is the place of therapy for TZDs?

A

3rd line
A1c Lowering 1-1.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Why is Rosiglitazone NOT so Rosy?

A

Can increase risk of MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is the primary action of GLP-1 Agonists?

A

Increase insulin secretion, decrease glucagon secretion (glucose DEPENDENT), slow gastric emptying, and increase satiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the brand name of Exenatide IR and ER?

A

IR: Byetta
ER: Bydureon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is the dosing for Byetta/Bydureon

A

Byetta: BID
Bydureon: once weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is the renal dosing for Byetta/Bydureon?

A

CrCl < 30 = DC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What is the brand name of Liraglutide?

A

Victoza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What is the dosing of Victoza?

A

QD for 1 week before titrating up dose strength

51
Q

What is the brand name for Dulaglutide?

A

Trulicity

52
Q

What is the dosing for Trulicity?

A

Once weekly

53
Q

What is the brand name for Lixisenatide?

A

Adlyxin

54
Q

What is the dosing for Adlyxin?

A

QD

55
Q

What is the brand name of Semaglutide?

A

Ozempic or Rybelsus

56
Q

What is the dosing for Ozempic/Rysbelsus?

A

Ozempic: once weekly
Rysbelsus: QD

57
Q

What are the A/Es of GLP-1 Agonists?

A

GI upset, nausea, vomiting, diarrhea

58
Q

What are the CIs of GLP-1 Agonists?

A

Personal or FH of medullary thyroid carcinoma (black box) EXCEPT for Lixisenatide

59
Q

What are the warnings for GLP-1 Agonists?

A

Acute pancreatitis, gallbladder disease, and gastroparesis

60
Q

What is the place in therapy for GLP-1 Agonists?

A

1st or 2nd line
A1c lowering 0.5-1.9%
CVD: Liraglutide, Dulaglutide, and Semaglutide

61
Q

Do GLP-1 Agonists promote weight loss?

A

Yes

62
Q

LEADER Result

A

Liraglutide-Risk reduction of major CV events in adults with type 2 DM and established CVD

63
Q

SUSTAIN 6 Results

A

Semaglutide-Risk reduction of major CV events in adults with type 2 DM and established CVD

64
Q

REWIND Results

A

Dulaglutide-Risk reduction of major CV events in adults with type 2 diabetes who have established CVD or multiple CV risk

65
Q

What is the primary action of DPP4 Inhibitors?

A

Indirectly increases insulin secretion and decreases glucagon secretion, glucose DEPENDENT

66
Q

What is the brand name of Sitagliptin?

A

Januvia

67
Q

What is the brand name of Saxagliptin?

A

Onglyza

68
Q

What is the brand name of Linagliptin?

A

Tradjenta

69
Q

What is the brand name of Alogliptin?

A

Nesina

70
Q

How are DPP4-Inhibitors dosed?

A

QD orally

71
Q

What are the A/E and Monitoring concerns of DPP4-Inhibitors?

A

Increased LFTs, monitor LFT and renal function

72
Q

What are the warnings for DPP4-Inhibitors?

A

HF: Saxagliptin and Alogliptin
Renal Impairment
Hepatotoxicity

73
Q

What is the place of therapy for DPP4-Inhibitors?

A

2nd or 3rd line
A1c lowering 0.6-0.8%

74
Q

Do DPP4-Inhibitors cause weight gain?

A

NO

75
Q

What is the primary action of SGLT2 Inhibitors?

A

Blocks glucose reabsorption by the kidney

76
Q

What is the brand name of Canagliflozin?

A

Invokana

77
Q

What is the brand name of Dapagliflozin?

A

Farxiga

78
Q

What is the brand name of Empagliflozin?

A

Jardiance

79
Q

What is the brand name of Ertugliflozin?

A

Steglatro

80
Q

How are SGLT2-Inhibitors dosed?

A

QD and orally

81
Q

What are the A/Es of SGLT-2 Inhibitors?

A

UTI, Genital mycotic infections

82
Q

What are warnings for SGLT2 Inhibitors?

A

Increased risk of bone fractures, ketoacidosis, lower limb amputations, fournier’s gangrene, and pancreatis

83
Q

What is the place in therapy for SGLT2 Inhibitors?

A

1st or 2nd line
A1c Lowering 0.5-1%

84
Q

Does SGLT2 Inhibitors cause weight gain?

A

NO

85
Q

Which SGLT2 Inhibitors have CVD benefits?

A

Canagliflozin, Empagliflozin, and Dapagliflozin

86
Q

Which SGLT2 Inhibitors have HF benefits?

A

Empagliflozin
Dapagliflozin for HFrEF

87
Q

What SGLT2 Inhibitors have CKD benefits?

A

Canagliflozin and Dapagliflozin

88
Q

EMPA-REG Results

A

Empagliflozin-Risk reduction of CV mortality in adults with type 2 and established CVD

89
Q

CANVAS Results

A

Canagliflozin-Risk reduction of CV mortality in adults with type 2 and CVD

90
Q

CREDENCE RESULTS

A

Canagliflozin-Risk reduction in ESRD, doubling of serum creatinine, CV death, and hospitalization for HF in adults with type 2 DM and diabetic nephropathy with urinary albumin excretion >300 mg/day

91
Q

DECLARE TIMI 58 RESULTS

A

Dapagliflozin-Risk reduction for hospitalization for HF in patients with type 2 diabetes and established CVD or multiple CV risk factors

92
Q

DAPA-HF RESULTS

A

Dapagliflozin-SEPARATE INDICATION, HFrEF to reduced the risk of hospitalization or death

93
Q

EMPEROR-Reduced RESULTS

A

Empagliflozin-August, 18, 2021 FDA approved indication for use in HF in adults with HFrEF

94
Q

EMPEROR Reserved RESULTS

A

Empagliflozin-February 4, 2022: FDA approved use in HF in adults with HFpEF

95
Q

DAPA-CKD RESULTS

A

Dapagliflozin-Adjunct therapy for CKD

96
Q

What the primary action of Alpha Glucosidase Inhibitors AGi?

A

Slows intestinal CHO digestion/absorption

97
Q

What is the brand name of Acarbose?

A

Precose

98
Q

What is the brand name of Miglitol?

A

Glyset

99
Q

How are AGi’s dosed?

A

TID with meals

100
Q

What are the A/E’s of AGi’s?

A

Significant in GI upset and Increased LFTs (Acarbose)

101
Q

What are the CIs of AGi?

A

Inflammatory bowel disease, colonic ulceration, intestinal obstruction, malabsorption disorders

102
Q

What is the place in therapy for AGi?

A

A1c lowering 0.3-1%

103
Q

What are the clinical pearls for AGi?

A

Minimal hypoglycemia, no weight gain, and TID dosing, and hepatotoxicty

104
Q

What is the primary action of Amylin Analogue?

A

Reduces postprandial elevations by prolonging gastric emptying, suppresses glucagon secretion, and produces satiety

105
Q

What is the brand name of Symlin?

A

Pramlintide?

106
Q

What are the A/E of Amylin Analogue?

A

Significant hypoglycemia (black box), HA, nausea, and anorexia

107
Q

What is the CI and warning associated with Amylin Analogues?

A

CI: gastroparesis
Warning: hypoglycemia

108
Q

What is the place of therapy for Amylin Analogues?

A

A1c lowering 0.6-0.8%

109
Q

What are the pearls for Amylin analogue?

A

Weight loss and decrease mealtime insulin by 50%

110
Q

What is the primary action for Dopamine 2 Agonists?

A

Increases insulin sensitivity

111
Q

What drug is a Dopamine 2-Agonist and its place in therapy?

A

Bromocriptine, A1c lowering 0.6-1.2% not commonly used

112
Q

What is the primary action for Bile Acid Sequestrant BAS?

A

Decrease hepatic glucose production and increase incretin levels

113
Q

What drug is a BAS and what is its place in therapy?

A

Colesvelam/Welchol, A1c lowering 0.5%

114
Q

What drugs are utilized for a therapy target of fasting blood glucose?

A

Biguanide, TZDs, SU, SGLT-2, Dopamine Agonists, Bromocriptine, DPP4, and GLP-1

115
Q

What drugs are utilized for therapy target postprandial blood glucose?

A

Meglitinide, DPP4, GLP-1, and AGi

116
Q

When do you measure for therapy target for postprandial blood glucose?

A

Pre and 2 hours after same meal or before the next meal

117
Q

When should you consider metformin for prediabetes patients?

A

BMI >35, Age <60, and Women with prior GDM

118
Q

What drugs categories should you avoid with HF?

A

TZDs and DPP4

119
Q

What drugs categories should you avoid with Renal Impairment?

A

Metformin

120
Q

What drugs categories should you avoid with GI Disorders?

A

AGi and GLP-1

121
Q

What drugs categories should you avoid with Bone Fractures?

A

SGLT2 and TZD

122
Q

What drugs categories should you avoid with Hepatotoxicity?

A

TZD, DPP4, and AGi

123
Q

What drugs categories should you avoid with Thyroid Carcinoma?

A

GLP-1

124
Q

What are the common barriers to monitoring and control?

A

Concurrent health conditions, life stressors with higher priority, inadequate knowledge, inadequate access, poor adherence, fear of hypoglycemia